Triple 000 and Sub-penny Chart Plays

[trader53]

DPLS - ENZC - Comparison Analysis


I'll Alert you of stocks to Buy,
before the Run happens !


_________________________________________________________________





ENZC Security Details
Share Structure
Market Value1...........$25,362,169 a/o Oct 19, 2020
Authorized Shares...3,000,000,000 a/o Sep 30, 2020
Outstanding Shares..2,438,670,097 a/o Sep 30, 2020
Restricted..............767,839,585 a/o Sep 30, 2020
Unrestricted..........1,670,830,512 a/o Sep 30, 2020
Held at DTC...........1,271,629,924 a/o Sep 30, 2020
Float.....................Not Available
Par Value 0.001

https://www.otcmarkets.com/stock/ENZC/security


_________________________________________________________________




DPLS Security Details
Share Structure
Market Value1...........$809,204 a/o Oct 19, 2020
Authorized Shares..20,000,000,000 a/o Sep 29, 2020
Outstanding Shares..3,236,817,156 a/o Sep 29, 2020
Restricted...............31,894,998 a/o Sep 29, 2020
Unrestricted..........3,204,922,158 a/o Sep 29, 2020
Held at DTC...............Not Available
Float.....................Not Available
Par Value 0.01

https://www.otcmarkets.com/stock/DPLS/security
https://www.otcmarkets.com/stock/DPLS/disclosure


Authorized Shares,
has No Bearing on the price.

The Shares Authorized,
is not used in any fundamental of financial calculation,
to determine company value.

_________________________________________________________________



_________________________________________________________________


ENZC - Price jumps to 0.0095

News Catalyst

September 16, 2020

https://www.otcmarkets.com/stock/ENZC/news/story?e&id=1693758

https://www.ldmicro.com/profile/enzc/news/7730961669761459

Enzolytics, Inc.
today announced
the execution of a non-binding
letter of intent (the "LOI")
to merge with

BioClonetics Immunotherapeutics, Inc.
("BCLS" or "BioClonetics")
a biotech company located in Dallas Texas.
_________________________________________________________________


Table Data

ENZC - Sep 16 - Historical Price and Volume
from Aug 28 thru Sep 18

https://www.otcmarkets.com/stock/ENZC/overview



_________________________________________________________________

Embedded and Live! Charts



_________________________________________________________________



_________________________________________________________________


ENZC - Price jumps to 0.0095

News Catalyst

September 16, 2020

https://www.otcmarkets.com/stock/ENZC/news/story?e&id=1693758

https://www.ldmicro.com/profile/enzc/news/7730961669761459

Enzolytics, Inc.
today announced
the execution of a non-binding
letter of intent (the "LOI")
to merge with

BioClonetics Immunotherapeutics, Inc.
("BCLS" or "BioClonetics")
a biotech company located in Dallas Texas.
_________________________________________________________________


Table Data

ENZC - Sep 16 - Historical Price and Volume
from Aug 28 thru Sep 18

https://www.otcmarkets.com/stock/ENZC/overview



_________________________________________________________________

Embedded and Live! Charts









_________________________________________________________________


ENZC - Price jumps to 0.0095

News Catalyst

September 16, 2020

https://www.otcmarkets.com/stock/ENZC/news/story?e&id=1693758

https://www.ldmicro.com/profile/enzc/news/7730961669761459

Enzolytics, Inc.
today announced
the execution of a non-binding
letter of intent (the "LOI")
to merge with

BioClonetics Immunotherapeutics, Inc.
("BCLS" or "BioClonetics")
a biotech company located in Dallas Texas.
_________________________________________________________________


Table Data

ENZC - Sep 16 - Historical Price and Volume
from Aug 28 thru Sep 18

https://www.otcmarkets.com/stock/ENZC/overview



______________________________________________________________








________________________________________________________________









________________________________________________________________









________________________________________________________________









________________________________________________________________









________________________________________________________________









________________________________________________________________